Caricamento...

Onset of Glycemic and Weight Outcomes in Patients Initiating Exenatide Once Weekly: The Relationship of Exenatide Exposure with Efficacy over the First 24 Weeks of Treatment

INTRODUCTION: Exenatide is gradually released from exenatide once weekly (QW) microspheres, and at steady state, consistently controls glycated hemoglobin (HbA1c) in patients with type 2 diabetes (T2D). This post hoc analysis examined the timing to onset of clinical responses and their correlations...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Diabetes Ther
Autori principali: Blevins, Thomas, Ruggles, James, Hardy, Elise
Natura: Artigo
Lingua:Inglês
Pubblicazione: Springer Healthcare 2016
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4900982/
https://ncbi.nlm.nih.gov/pubmed/27146799
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13300-016-0172-0
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !